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Abstract
Background: Diabetes Mellitus has become a global epidemic and presents many complications, usually propor-
tional to the degree and duration of hyperglycemia. The aim of this systematic review was to investigate the dif-
ferent oral manifestations associated with Diabetes Mellitus. 
Material and Methods: A MEDLINE search for “Diabetes Mellitus and oral manifestations” was performed. 
A further search was conducted for “diabetes” and its individual oral manifestation. Inclusion criteria were as 
follows: human clinical studies with a minimum of 30 patients; studies published in relevant scientific journals 
between January 1998 and January 2016. Nineteen studies fulfilled the inclusion criteria and were analyzed, as-
sessing the strength of scientific evidence according to recommendations made by the Centre for Evidence-Based 
Medicine, Oxford (OCEBM), which permits adequate assessment of prevalence studies. 
Results: A total 3,712 patients (2,084 diabetics) were included in the studies reviewed. Of the 19 studies analyzed, 
4 were longitudinal studies and 15 cross-sectional studies. Periodontal disease, periapical lesions, xerostomia and 
taste disturbance were more prevalent among diabetic patients. An association between diabetes and caries and 
mucosal lesions proved positive in 5 out of 10 studies. 
Conclusions: Despite multiple oral manifestations associated with DM, awareness of the associations between 
diabetes, oral health, and general health is inadequate. It is necessary for doctors and dentists to be aware of the 
various oral manifestations of diabetes in order to make an early diagnosis.
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Introduction
Diabetes Mellitus (DM) is a metabolic disorder char-
acterized by the presence of chronic hyperglycemia ac-
companied to greater or lesser extent by alterations to 
carbohydrate, protein, and lipid metabolisms. DM has 
become a global epidemic, the complications of which 
significantly impact on the quality of life and longevity 
of the sufferers, as well as healthcare costs. The number 
of people with diabetes has increased from 108 million 
in 1980 to 422 million in 2014. The overall prevalence of 
diabetes among adults over 18 years of age has increased 
from 4.7% in 1980 to 8.5% in 2014 and the World Health 
Organization (WHO) predicts this will increase to 439 
million, almost 10% of adults in 2030 (1). 
Patients with diabetes present impaired function of 
polymorphonuclear leukocytes (leukocyte adhesion, 
chemotaxis, and phagocytosis), impaired bactericidal 
activity, altered response to exposure to antigens, and 
alteration to the function of T lymphocytes (2). Many 
studies have shown a clear link between chronic inflam-
mation and the development of Type 2 Diabetes Melli-
tus (DM2) (2,3).  
Both Diabetes Mellitus type 1 (DM1) and type 2 diabe-
tes (DM2) present numerous possible long-term compli-
cations. Epidemiological studies indicate that the sever-
ity of diabetic complications is generally proportional 
to the degree and duration of hyperglycemia (4). Among 
the oral manifestations related to DM described are: dry 
mouth, tooth decay, periodontal disease and gingivitis, 
oral candidiasis, burning mouth syndrome (BMS), taste 
disorders, rhinocerebral zygomycosis (mucormycosis), 
aspergillosis, oral lichen planus, geographic tongue and 
fissured tongue, delayed wound healing, and increased 
incidence of infection, salivary dysfunction, altered 
taste and other neurosensory disorders, impaired tooth 
eruption, and benign parotid hypertrophy (5). The ob-
jective of this review was to provide a systematic over-
view of the literature on the various oral manifestations 
that may occur in diabetic patients.
Material and Methods  
This systematic review was conducted in order to an-
swer the question: what are oral the manifestations of 
diabetes? The review followed guidelines detailed in 
Preferred Reporting Items for Systematic Reviews and 
Meta-analysis (PRISMA) (6).
- Database Selection
Two blinded reviewers (JL and EM) made the study se-
lection according to inclusion/exclusion criteria. Both 
reviewers agreed with the selection of articles.
- Search strategy
A literature search was performed in the MEDLINE 
database applying the search terms “Diabetes and Oral 
manifestations,” selecting transverse and longitudinal 
human studies published between January 1998 and 
January 2016. A further search was then performed us-
ing the terms “Diabetes Mellitus” combined with dif-
ferent oral manifestations: “Dental Caries”; “Periapical 
lesions”; “Periodontal disease”; “Salivary dysfunction”; 
“Oral mucosal pathology”; “Taste alteration”; “Burning 
mouth syndrome.” Other studies were located using the 
Cochrane database and other academic search engines 
available via Google, or obtained from the reference 
lists of review articles.
- Screening and selection 
Studies were selected applying the following inclusion 
criteria: articles published in English, between January 
1998 and January 2016, in scientific journals, original 
research, studies conducted on a human population, 
with more than 30 patients. Exclusion criteria were: ani-
mal studies, in vitro studies, studies with fewer than 30 
patients, not original papers, systematic reviews, meta-
analyses.
- Data extraction and statistical analysis
Data were collected by two independent reviewers (JL 
and EM). A tab-based data collection protocol was 
designed for the 19 items included in the review. The 
review was performed following guidelines detailed in 
the PRISMA statement, aimed at to improving the qual-
ity of systematic reviews and meta-analyses (6). The 
reviewers crosschecked all extracted data. Disagree-
ments were resolved by discussion until consensus was 
reached.  
- Methodological study quality assessment
The quality of the articles was assessed by two indepen-
dent reviewers. The strength of scientific evidence was 
rated following recommendations made by the Cen-
tre for Evidence-Based Medicine, Oxford (OCEBM), 
which allows adequate assessment of studies of disease 
prevalence (7). 
Results
The search conducted using the MEDLINE database 
identified 170 published articles. After reading the ab-
stracts, 39 works were selected of which only nine met 
the inclusion criteria: human studies published between 
1998 and 2016, and with a minimum sample of 30 pa-
tients with DM1 and/or DM2. Twenty articles were 
excluded as they were reviews, two because they were 
case reports, two animal studies, one as it included few-
er than 30 patients, one as it was not available in Eng-
lish, and four that did not deal specifically with the oral 
manifestations of DM. A parallel search applying the 
search terms “Diabetes Mellitus” in combination with 
the various relevant oral manifestations, and a search 
among the references included in literature reviews 
identified a further ten studies. See Flow chart Diagram 
in Figure 1.
The final selection of articles included a total of 3,712 
patients, of whom 2,084 had diabetes. Of the 19 studies 
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included in the review, four were longitudinal studies 
and 15 cross-sectional studies. Of these, 14 (74%) found 
a higher prevalence of oral manifestations in patients 
with DM (8-21), while the remaining 5 (26%) did not 
obtain any significant differences between DM groups 
and control groups of healthy subjects (22-26). Of these, 
three explored the association of caries with DM (24-
26) and two the association of mucosal lesions with DM 
(22,23). 
Two studies dealt with the association between peri-
odontal disease (PD) and DM (8,24), and three the as-
sociation of periapical lesions with DM (9-11); all these 
five articles (100%) identified significant differences be-
tween patients with DM and control groups of healthy 
subjects. All studies (100%) investigating xerostomia 
(18-21), and taste alteration (17) found a higher incidence 
of these pathologies among diabetic patients compared 
to non-diabetic patients (Table 1). As regards other oral 
manifestations, the results generated some controversy. 
Of studies examining caries, 40% (12,13) found an as-
sociation with DM, while 60% did not (24-26); of those 
that evaluated the presence of mucosal lesions, 50% (14-
16) found an association with diabetes and 50% did not 
(22-24). 
Assessment of the strength of scientific evidence 
(OCEBM) showed that longitudinal studies presented 
stronger scientific evidence. Of the 4 longitudinal stud-
ies included in this review two investigated the pres-
Fig. 1. Flow chart diagram.
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Study Design LE GR Sample Sex Manifestation
Association 
with DM
Arrieta-Blanco 
et al., 2003 (8)
Transversal 4 C
70DM
74Healthy
30M, 40W
29M, 45W
Periodontal 
Disease
Yes
López-López 
et al., 2011 (9) 
Transversal 4 C
50DM2
50Healthy
20M, 30W
22M, 28W
Periapical 
Lesion
Yes
Wang et al., 
2011 (10)
Longitudinal 
Prospective
2 years
1B A 49.334* -
Periapical 
Lesion Yes
Fouad 2003 (11)
Longitudinal 
Prospective
2 years
1B A
74*
464**
-
Periapical 
Lesion
Yes
Lin et al.,
(12) 1999 Transversal 4 C
24 DM
18 Healthy
10M, 14W
10M, 8W
Caries Yes
Pa et al., 
2001 (13) 
Longitudinal 
Prospective
6-8 years
1B A
390DM1
202 Healthy
199M, 191W
76M, 126W
Root Caries Yes
Bharateesh 
et al., 2012 (25) 
Transversal 4 C
300 DM
300 Healthy
186M, 114W, 
180M, 120W
Caries No
Arrieta-Blanco 
et al., 2003 (26)
Transversal 4 C
70 DM1,2
74 Healthy
30M, 40W
29M, 45W
Caries No
Miralles et al., 
2002 (24)
Transversal 4 C
30 DM1
30 Healthy
-
Caries
Mucosal Lesion
PD
No
No
Yes
Kadir et al., 
2002 (14) 
Transversal 4 C
45 DM1,2
55 Healthy
18M27W
26M, 29W
Mucosal Lesion
(Candida)
Yes
Guggenheimer, 
2000 (15)
Transversal 4 C
405 DM1
268 Healthy
- Mucosal Lesion Yes
Study Design LE GR Sample Sex Manifestation
Association 
with DM
Petrou-Ameri-
kanou et al., 
1998 (16)
Transversal 4 C
135 DM1
353 DM2
274 Healthy
65M, 74W
127M, 225W 
110M,164W
Mucosal Lesion
(Lichen planus)
Yes
Cristina de 
Lima et al., 
2008 (22) 
Transversal 4 C
30 DM
30 Healthy
11M, 19W
9M, 21W
Mucosal Lesion No
Sousa et al., 
2011 (23) 
Transversal 4 C
96 DM2
100 Healthy
31M, 65W
27M, 73W
Mucosal Lesion No
Busato et al., 
2012 (18)
Transversal
4
C
51 DM1
51 Healthy
- Xerostomia Yes
Ivanoski et al., 
2012 (19)
Transversal 4 C
30 DM1
30 Healthy
- Xerostomia Yes
Carda et al., 
2006 (20) 
Transversal 4 C 17 DM216 Healthy
10M, 7W
8M, 8W
Xerostomia Yes
Chavez et al., 
2001 (21) 
Longitudinal 
Prospective
1 year
1B A
24 DM
15 Healthy
10M, 14W
9M, 6W
Xerostomia Yes
Stolbova et al., 
1999 (17)
Transversal 4 C
73 DM2
11 DM1
12 Obese
29 Healthy
26M, 47W
4M, 7W
4M, 8W
6M, 23W
Taste distur-
bance
Yes
Table 1.  Studies included in the review.
EL: Evidence level. GR: Grade recommendation. PD: Periodontal disease. M: Men. W: Women.
* Teeth endodontic patients with DM, ** Teeth endodontic patients without DM, (-) Unknown or not described.
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ence of periapical lesions (10,11) (49,334 and 538 teeth 
treated endodontically, respectively); one the presence 
of caries (13) (592 patients); and another the presence 
of xerostomia (21) (39 patients). All these longitudinal 
studies found the diseases studied to be associated with 
DM. 
Discussion
- Pathophysiology of oral manifestations
Two mechanisms involved are involved in the pathogen-
esis of diabetic complications. Firstly, the polyol path-
way converts glucose into the enzyme sorbitol byaldose 
reductase that causes tissue damage and numerous 
other diabetic complications. Secondly, the formation 
of advanced glycosylation end products (AGE), whose 
formation is due to binding of glucose to proteins, lipids 
and nucleic acids, results in the alteration of structures 
and functions, in addition to its deposition in specific or-
gans that causes various complications (27). Atheroma 
deposits are formed in cells, which accumulate in the 
basal membrane and lumen causing decreased cellular 
defense capacity and impaired polymorphonuclear leu-
kocyte response (28). This makes diabetic patients more 
susceptible to infection processes especially when these 
are caused by anaerobic bacteria due to the reduction of 
oxygen diffusion through the capillary wall (29).  
Figure 2 summarizes the most significant aspects of the 
pathophysiological relationship between diabetes and 
dental disease; the figure is based on a diagram pro-
posed by Kudiyirickal MG et al. (30). Table 2 shows the 
pathophysiology, treatment, and prevention aspects of 
orofacial diseases related to diabetes (30). 
- Oral manifestations of Diabetes Mellitus
For years, research into diabetes has explored the many 
clinical implications of this highly prevalent disease. As 
previously mentioned, these include the need for peri-
odontal control as tissue destruction may be accelerated 
among diabetics, and early management of oral infection 
will avoid exacerbating the existing metabolic imbal-
ance. It has been found that an individual with uncon-
trolled diabetes presents a higher risk of infection, as well 
as abnormal prolonged healing time that will endanger 
the health of the oral cavity. Research has established that 
patients with DM may present a variety of oral manifes-
tations (Table 3). Each of these oral manifestations and 
their relationship to DM are summarized below:
i. Diabetes and Periodontal Disease
The main oral complication attributed to diabetes is 
periodontal disease (PD), considered the sixth compli-
cation of DM (31). Simple chewing can cause systemic 
dissemination of periodontal pathogens and their meta-
bolic products in patients with periodontal disease caus-
Fig. 2. Pathophysiological relationship between diabetes and dental disease. Kudiyirickal adaptation of Kudiyirickal & 
Pappachan (30).
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Oral pathology related to DM Pathogenesis Treatment and Prevention
Periodontal disease
Accumulation of AGEs in periodontal 
tissues, decreased periodontal regenerative 
capacity and defective immune regulation
Assessment of risk of disease progression, 
periodic reviews, dietary advice and 
perio-dontal therapy
Dry mouth Reduced salivary flow as a result of polyuria and dehydration Proper control diabetes and dental hygiene
Root Caries As a result of gingival resorption and 
decreased salivary flow
Use of fluoridated pastes, restorative 
treatments. The optimal glycemic control 
prevents progression
Oral Candidiasis 
Because salivary dysfunction, 
hyperglycemia and impaired immune 
system
Antifungal nystatin or miconazole 
treatment. Good glycemic control and 
prevention
Pulp necrosis and periodontal 
abscess
Ischemic tissue damage related pulp own 
vascular damage from diabetes
Endodontic treatment and control of 
diabetes
Delayed wound healing and 
increased incidence of 
infections following surgery
Caused by vascular dysfunction and 
decreased immune on diabetes
Preventive administration of antibiotics and 
good glycemic control
Table 2. The pathophysiology, treatment and prevention aspects of orofacial diseases related to diabetes (30).
*AGEs: advanced glycosylation end products.
Oral manifestations Transversal Longitudinal 
Periodontal Disease Arrieta-Blanco et al., 2003(8)Miralles et al., 2002 (24) 
Periapical Pathology López-López et al., 2011 (9) Wang et al., 2011(10) 
Fouad 2003 (11)
Caries
Arrieta-Blanco et al., 2003 (26) 
Lin et al., 1999 (12)
Miralles et al., 2002 (24) 
Bharateesh et al., 2012 (25)
Pa et al.,2001 (13) 
Xerostomia, hyposalivation
Busato et al., 2012 (18)
 Cristina de Lima et al., 2008 (22)
 Sousa et al.,2011 (23)
 Ivanoski et al., 2012 (19)
 Carda et al., 2006 (20) 
Miralles et al., 2002 (24)
Chavez et al., 2011 (21) 
Taste disturbance and BMS Stolbová et al.,1999 (17)
Mucosal oral pathology
Cristina de Lima et al., 2008 (22) 
Sousa et al.,2011 (23) 
Kadir et al., 2002 (14)
Guggenheimer.,et al 2000 (15) 
Petrou-Amerikanou et al., 1998 (16)
Miralles et al., 2002 (24)
Table 3. Significant oral manifestations related to diabetes.
BMS: Burning Mouth Syndrome.
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ing endotoxemia or bacteremia, which results in an in-
crease in serum levels of inflammatory mediators such 
as Interleukin 6 (IL-6), fibrinogen, and C-reactive pro-
tein (CRP). Furthermore, systemic inflammation can 
exacerbate insulin resistance and therefore the manage-
ment of diabetes. For this reason, correct periodontal 
treatment can lower the level of proinflammatory medi-
ators, and so contribute to better glycemic control (30).
It has been suggested that there is a degree of synergism 
between DM and PD. On the one hand, the severity and 
prevalence of PD increases in diabetics and is worse in 
diabetics with poor glycemic control. On the other hand, 
periodontitis may exacerbate diabetes, decreasing gly-
cemic control. However, there is some controversy over 
this issue; diabetes clearly increases the risk of PD but the 
impact of PD on glycemic control and the mechanisms by 
which this occurs are not clear (32). 
ii. Diabetes and Periapical Pathology
The scientific literature shows a higher prevalence of 
periapical lesions in patients with poorly controlled 
diabetes (28,29). A recent clinical study showed that 
patients with DM2 presented a significant association 
with an increased incidence of periapical lesions and 
endodontic treatments (9). Regarding the success rate of 
endodontic treatment, an article published in 2011 (33) 
states that patients with DM had a lower success rate in 
primary root canal treatment in comparison with non-
diabetic patients, while both groups presented the same 
success rate in secondary root canal treatment (33). 
Another study found that patients with diabetes are at 
increased risk of the need for tooth extraction follow-
ing endodontic treatment. This risk increases in patients 
with hypertension as well as DM and /or coronary ar-
tery disease (10). 
The dental pulp of diabetic patients may have lim-
ited dental collateral circulation, impaired immune re-
sponse, and an increased risk of infection or pulp ne-
crosis. Regarding molecular pathology, hyperglycemia 
is a stimulus for bone resorption, inhibition of osteo-
blast differentiation, and a reduced capacity for bone 
recovery (34). It has been observed that the removal of 
periodontal inflammation can reduce the dose of insu-
lin required for the patient’s glycemic control. For this 
reason, it is essential to remove all dental pulp infec-
tions (28). The special characteristics of periapical le-
sions in patients with diabetes provide evidence that the 
treatment objectives and definition of success should be 
different for these patients. A recent review concluded 
that current knowledge about the microbiology of endo-
dontic infections and inflammatory reactions is limited, 
and that such knowledge could help implement new 
forms of treatment for these patients. Further research 
is needed to better understand the issue and so increase 
the success rates of endodontic treatment among these 
patients (34).
iii. Diabetes and Dental Caries
Information presented in the literature about the rela-
tionship between the DM and tooth decay is inconsistent 
(35). Arrieta-Blanco et al. (26) in a study of 144 patients 
(70 diabetic and 74 non-diabetic) found no significant 
difference in mean caries between the two groups. The 
prevalence of carious lesions was 7.39% in diabetic pa-
tients and 6.91% in non-diabetics (26). Another study 
with a sample of 600 patients (300 with diabetes and 
300 healthy) showed that the prevalence of dental caries 
was higher in non-diabetics (32.3%) than in diabetics 
(13.6 %)(25). As shown in Table 4, patients with DM 
had greater need for treatment than healthy subjects, 
but nevertheless presented a lower rate of tooth decay. 
Bharateesh et al., suggest that patients with DM may 
have fewer cavities due to the content of their diet which 
usually contains more protein and fewer fermentable 
carbohydrates (25). Another similar study did not find 
differences in the number of cavities between patients 
with DM1 and a group of healthy subjects (24). 
Caries
Periodontal 
disease
Treatment 
need 
DM 13,6% 92,6% 58%
NO DM 32,3% 83% 41%
Table 4. Results study of Bharateesh (25).
Meanwhile, other studies have found a higher incidence 
of dental caries in patients with DM (12,13), which 
could be explained by the decrease of salivary secretion 
suffered by diabetics.
iv. Diabetes and Oral Mucosa
DM Patients may have a higher prevalence of mucosal 
disorders possibly associated with chronic immunosup-
pression, delayed healing, and/or salivary hypofunction 
(14). These alterations include: oral fungal infections 
such as oral candidiasis (15); fissured tongue, irritation 
fibroma, traumatic ulcers and lichen planus (16). How-
ever, there is some controversy on this issue, as other 
studies have found no association between DM and can-
didiasis, or other oral mucosa lesions (22-24).  
v. Diabetes and Xerostomia
In a study conducted by Chavez et al. (21), a tendency 
for salivary flow to decrease was observed when HbA1c 
values increased. A recent study compared the salivary 
characteristics in 30 patients with diabetes compared 
with 30 healthy subjects. Eighty per cent of DM patients 
presented xerostomia, but only 10% of healthy subjects. 
Furthermore, urea and glucose levels in saliva were sig-
nificantly higher in diabetics than healthy subjects. This 
suggests that DM can cause xerostomia and that there 
may be a significant correlation between the degree of 
xerostomia and glucose levels in saliva. In addition, in-
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creased salivary glucose promotes the proliferation and 
colonization of bacteria in the oral cavity, and glucose is 
the basis for Candida development and decreases the ac-
tivity of neutrophils (19). Another study of 102 patients 
showed a significant association between DM1 and xe-
rostomia but the results showed that clinical status and 
salivary conditions did not affect the presence of xeros-
tomia (18). Carda et al. (20), in a study of 33 patients, 
found a significantly higher percentage of xerostomia 
in patients with DM than in the control group (76.4% 
and 18.7% respectively). However other studies have not 
found significant differences in salivary flow between 
diabetics and non-diabetics (22,23).
vi. Diabetes and Taste disturbance
Taste detection follows a hereditary pattern, but can be 
influenced by the appearance of neuropathies. When 
this sensory dysfunction occurs, it can inhibit the abil-
ity to maintain a proper diet and can lead to poor gly-
cemic control. Taste alteration has been associated with 
diabetes and the development of obesity (36). In this 
context, a 1999 clinical study investigated 73 patients 
with DM2, 11 patients with DM1, 12 obese patients 
(BMI> 30) without DM, and 29 control subjects. All 
subjects underwent electrogustometric examination. 
The results found hypogeusia in 40% of DM2 patients, 
in 33% of DM1 patients, 25% of obese patients, while 
no case of hypogeusia was found in the control group. 
Ageusia was observed in 5% of DM2 patients, 3% of 
DM1 patients, and 14% of obese patients. These results 
suggest that impaired taste may evoke hyperphagia, and 
then later, obesity (17).
vii. Diabetes and Burning Mouth Syndrome
Burning mouth syndrome (BMS) is characterized by a 
burning sensation in the oral mucosa and an absence of 
clinical signs. Its etiology includes systemic, local, and 
psychological factors (stress, anxiety and depression). It 
is more common in women, and the average age of the 
typical SBA patients is 50 to 60 years old (37). Patients 
with diabetes often have burning mouth syndrome, but 
a clear relationship between DM and BMS has not been 
identified (38). 
- Knowledge of the relationship between diabetes and 
oral health
Knowledge and understanding of diabetes and peri-
odontal health is low among diabetic patients, and most 
are unaware of the oral health complications deriving 
from the disease they suffer and of the need for proper 
preventive care. This was reflected in a recent study in 
which questionnaires were issued to a random sample 
of 500 diabetic patients. Twenty-eight per cent of pa-
tients said they did monitor their periodontal health 
with regular visits to the dentist; 48% were conscious 
of the increased susceptibility to gum disease and oral 
health complications; 38% recognized that periodontal 
health can affect blood sugar levels (39). Another study 
of 101 patients with DM1 and DM2, found that 84% of 
the increased risk of heart disease, 98% of the risk of 
eye disease, 99% of the risk of circulatory problems and 
94% of the risk of kidney disease but only 33% of the 
participants were aware of the increased risk of peri-
odontal disease. The participants who were aware of 
the increased risk of periodontal disease had obtained 
this information from a dentist. The study also found 
a significant association between metabolic control and 
dental status (40). 
Awareness and understanding of the possible associa-
tions between diabetes, oral health and general health 
need to be increased among diabetic patients. Dentists, 
doctors and other health professionals should conduct 
periodontal screening every time a diabetic patient at-
tends a check-up, and should recommend attending reg-
ular check-ups by a specialist (39,40). All the evidence 
registered in the present review highlights the impor-
tance of preventive and therapeutic control of DM and 
periodontal disease. The involvement of oral health pro-
fessionals in strategies aimed at identifying individuals 
at risk from diabetes should be maximized in order to 
retard the development of possible complications (36). 
As for the dentist’s involvement in these strategies, 
he/she should bear in mind that diabetes is a common 
disease with concomitant oral manifestations that can 
modify dental care needs. In this context, dentists must 
be completely familiar with diagnosis and prevention 
techniques (39,40). Effective management of diabetic 
patients requires cooperation between the patient, the 
doctor, the dentist, and other healthcare professionals. 
Regular check-ups will allow dentists to anticipate pa-
tient needs and interact competently with other health-
care professionals. Careful examination of the oral cav-
ity may discover indications of an underlying systemic 
condition, and allow early diagnosis and treatment. The 
examination should include an assessment of changes to 
the mucosa, periodontal inflammation, and bleeding, as 
well as the general state of the teeth.
Conclusions
Diabetes Mellitus leads to multiple complications, 
which increase when glycemic control of the patient 
is inadequate. This makes management and preven-
tion important. It has been shown that diabetes exists 
in a bidirectional relationship with periodontal disease 
and may lead to other oral pathologies. For this reason, 
doctors and dentists must be vigilant with regard to the 
various oral manifestations of diabetes in order to make 
an early diagnosis.
Full understanding and awareness of the pathophysiol-
ogy, manifestations, and management of different types 
of diabetes-related orofacial infection by the endocri-
nologist and the dentist are essential to optimizing the 
care of diabetic patients.
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